3174 results for «516»

Filter By

3174 results

Problem-solving in challenging TAVI cases

11 Sep 2025 – From PCR Rio Valves 2025

Explore complex and challenging TAVI cases with expert-led discussions covering redo TAVI procedures, horizontal aorta anatomy, rapid pacing protocols, lithotripsy-assisted interventions for severe calcific stenosis, and management of procedural complications including valve dislodgement.

TAVI - Take the first step considering life time management

12 Sep 2025 – From PCR Rio Valves 2025

Understand the critical importance of lifetime management in TAVI, emphasizing how the initial procedure impacts long-term results. This session discusses implantation depth, commissural alignment, and their roles beyond coronary access, illustrated through a low-risk young patient case and current durability data.

TAVI - Take the first step considering life time management

Redefining and optimising LAA closure - LIVE Case

11 Sep 2025 – From PCR Rio Valves 2025

Supported by an unrestricted educational grant from Boston Scientific

A 78-year-old woman with atrial fibrillation and obesity (BMI 34.3), normal left ventricular function, CHADS-VASCs 5 and HAS-BLED 4, presented with severe gastrointestinal bleeding.

She underwent implantation of a Watchman FLX™ pro under local anesthesia via two right femoral...

Redefining and optimising LAA closure - LIVE Case

Mitral challenges: from paravalvular leaks to valve-in-valve

12 Sep 2025 – From PCR Rio Valves 2025

Explore complex mitral valve challenges including paravalvular leaks, valve-in-valve implantation, and comprehensive percutaneous cardiac reconstructions. This session highlights innovative percutaneous solutions for surgical no-go zones, haemolytic leaks, and multi-territory device therapies to improve patient outcomes.

TAVI in complex anatomy: high stakes and tight spaces

12 Sep 2025 – From PCR Rio Valves 2025

Address the high-stakes challenges of TAVI in complex anatomical scenarios. This session discusses high-risk valve-in-valve interventions, management of delayed coronary obstruction, procedures in small annuli, and innovative bailout strategies including carotid TAVI.

Precision in mitral TEER

11 Sep 2025 – From PCR Rio Valves 2025

Join this live educational session from Bordeaux University Hospital to gain expert insights into mitral transcatheter edge-to-edge repair (TEER). Explore optimal timing and clinical decision-making for mitral regurgitation treatment, and discover how the PASCAL Precision system enhances procedural precision across diverse mitral anatomies. Witness real-time strategies,...

Precision in mitral TEER: LIVE Educational Case from Bordeaux University Hospital - Bordeaux, France

Tricuspid valve - How to evaluate?

12 Sep 2025 – From PCR Rio Valves 2025

This session offers a detailed evaluation framework for the tricuspid valve, encompassing clinical decision-making, anatomical assessment with 2D and 3D imaging, quantification of regurgitation, and differentiation of secondary and device-related tricuspid regurgitation, supported by advanced imaging software techniques.

All you need to know about transcatheter tricuspid therapies

11 Sep 2025 – From PCR Rio Valves 2025

Delve into the evolving field of transcatheter tricuspid therapies with this comprehensive session. Understand tricuspid valve anatomy and imaging modalities, discuss optimal timing for intervention in tricuspid regurgitation, and review current and emerging transcatheter treatment options. Case presentations illustrate practical applications and outcomes to support clinical...

All you need to know about transcatheter tricuspid therapies

TAVI outcomes in special clinical settings: cancer, diabetes, and frailty

12 Sep 2025 – From PCR Rio Valves 2025

Delve into the complexities of TAVI outcomes in special clinical populations including patients with cancer, diabetes, and frailty. This session reviews critical analyses and meta-analyses addressing ischemic cerebrovascular events post-TAVI, and compares mortality and post-procedural outcomes between diabetic and non-diabetic patients, providing valuable insights for personalized...

Mitral valve - How to evaluate?

11 Sep 2025 – From PCR Rio Valves 2025

This educational session focuses on comprehensive evaluation of the mitral valve to guide clinical decision-making. Topics include risk stratification and patient selection for Mitral TEER, detailed anatomy review, assessment of primary and secondary mitral regurgitation phenotypes, advanced quantification techniques per current guidelines, and pre-intervention transoesophageal echocardiography...

TMVR today: devices, challenges, and clinical learnings

12 Sep 2025 – From PCR Rio Valves 2025

Explore the evolving landscape of transcatheter mitral valve replacement (TMVR) with a focus on innovative devices, procedural challenges, and clinical learnings. Through a series of case reports, including novel atrial fixation prostheses, devices addressing left ventricular outflow tract obstruction, and complex MitraClip interventions, this session highlights...

Seal the deal: echocardioraphy-guided LAA closure for stroke defense

12 Sep 2025 – From PCR Rio Valves 2025

This session focuses on echocardiography-guided left atrial appendage (LAA) closure as a critical strategy for stroke prevention. Attendees will explore optimal cardiac imaging techniques tailored to evolving clinical needs and seasonal considerations. The session also includes comprehensive instruction on post-procedural echocardiographic assessment and post-processing workflows in...

Valve-in-valve and coronary protection

11 Sep 2025 – From PCR Rio Valves 2025

Explore complex valve-in-valve procedures and coronary protection strategies through a series of challenging case presentations. Topics include management of high-risk valve-in-valve scenarios, strategies for degenerated aortic bioprostheses, innovative transcarotid approaches, fenestration stenting for late coronary obstruction, and analysis of valve embolisation events, providing valuable insights for...

Management of mitral regurgitation patients undergoing TMVI screening

13 Jan 2022

This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.

Management of mitral regurgitation patients undergoing TMVI screening
Didn’t find what you were looking for?